CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
复制标题
DOI:
10.1158/0008-5472.can-20-1049
复制
发表时间:
2020-09-15
期刊:
影响因子:
11.2
通讯作者:
Luo W
中科院分区:
文献类型:
--
作者:
Wang Y;Chen Y;Bao L;Zhang B;Wang JE;Kumar A;Xing C;Wang Y;Luo W
Recruitment of RNA polymerase II to hypoxia-inducible factor (HIF) target genes under normoxia is a prerequisite for HIF-mediated transactivation. However, the underlying mechanism of this recruitment remains unknown. Here we report that chromodomain helicase DNA-binding protein 4 (CHD4) physically interacts with αand β subunits of HIF-1 and HIF-2 and enhances HIF-driven transcriptional programs to promote breast cancer progression. Loss of HIF-1/2α abolished CHD4-mediated breast tumor growth in mice. In breast cancer cells under normoxia, CHD4 enrichment at HIF target gene promoters increased RNA polymerase II loading through p300. Hypoxia further promoted CHD4 binding to the chromatin via HIF-1/2α, where CHD4 in turn enhanced recruitment of HIF-1α, leading to HIF target gene transcription. CHD4 was upregulated and correlated with HIF target gene expression in human breast tumors; upregulation of CHD4 and other known HIF coactivators in human breast tumors was mutually exclusive. Furthermore, CHD4 was associated with poor overall survival of breast cancer patients. Collectively, these findings reveal a new fundamental mechanism of HIF regulation in breast cancer, which has clinical relevance.